EBS Emergent BioSolutions Inc. Common Stock
NYSE · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$6.33
· of 52w range
· above low
· to high
$4.3652w low
$14.0652w high
Market Cap (MRQ)
$325M
P/E (TTM)
-1.8
EPS (TTM)
$-3.46
Revenue (TTM)
$770M
your badges
52W Range
$4–$14
Analyst Rating
BUY
Price Target
$11
P/E
-1.8
ROE
-40.3%
Net Profit Margin
-23.0%
Your badge strip is empty — pin a metric anywhere on this page.
EBS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.33
Market Cap (MRQ)
$325M
P/E (TTM)
-1.8
EPS (TTM)
$-3.46
Revenue (TTM)
$770M
ROE (TTM)
-40.3%
Debt/Equity (MRQ)
1.7
52W Range
$4–$14
EBS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$743M2017-12-31 → 2025-12-31
EPS$0.932017-12-31 → 2025-12-31
Free Cash Flow$157M2017-12-31 → 2025-12-31
Net margin-23.0%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | EBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.85Y avg ≈1.9 | ≈1.9 | · | · | |
| P/S (TTM) | 0.45Y avg ≈0.5 | ≈0.5 | 25.7 | Undervalued | |
| P/B (MRQ) | 1.05Y avg ≈0.8 | ≈0.8 | 2.5 | Undervalued | |
| EV / EBITDA | 3.65Y avg ≈3612.0 | ≈3612.0 | · | · | |
| Price / FCF (TTM) | 3.85Y avg ≈6.0 | ≈6.0 | · | · | |
| Price / Cash Flow (TTM) | 3.35Y avg ≈4.0 | ≈4.0 | · | · | |
| EV / Revenue | 0.95Y avg ≈1.2 | ≈1.2 | · | · | |
| EV / FCF | 4.45Y avg ≈10.6 | ≈10.6 | · | · | |
| Price / Tangible Book (MRQ) | 4.15Y avg ≈3.4 | ≈3.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | EBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -8.6%5Y avg ≈-20.3% | ≈-20.3% | -209.1% | Top tier | |
| EBITDA Margin (TTM) | 3.7%5Y avg ≈-11.5% | ≈-11.5% | -209.1% | Top tier | |
| Pretax Margin (TTM) | -19.0%5Y avg ≈-23.0% | ≈-23.0% | -245.7% | Top tier | |
| Net Profit Margin (TTM) | -23.0%5Y avg ≈-25.7% | ≈-25.7% | -246.0% | Top tier | |
| ROA (TTM) | -14.0%5Y avg ≈-12.8% | ≈-12.8% | -49.3% | Top tier | |
| ROE (TTM) | -40.3%5Y avg ≈-47.2% | ≈-47.2% | -64.8% | Top tier | |
| ROIC | 5.8%5Y avg ≈-15.4% | ≈-15.4% | -100.1% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | EBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 1.75Y avg ≈1.5 | ≈1.5 | · | · | |
| Current Ratio (MRQ) | 5.45Y avg ≈3.2 | ≈3.2 | 5.1 | In line | |
| Quick Ratio | 2.25Y avg ≈1.4 | ≈1.4 | 2.9 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 1.75Y avg ≈1.1 | ≈1.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | EBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -28.8%5Y avg ≈-18.1% | ≈-18.1% | · | · | |
| Revenue CAGR 3Y | -12.7%5Y avg ≈-13.9% | ≈-13.9% | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | EBS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.5 | ≈0.5 | 0.1 | Top tier | |
| Inventory Turnover | 1.0 | · | · | · | |
| Receivables Turnover | 6.25Y avg ≈6.1 | ≈6.1 | 2.6 | Top tier | |
| Revenue / Employee | ≈$825.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
217.1%
Next Report
Oct 27, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $0.60 | $0.11 | 440.1% |
| March 31, 2026 | May 13, 2026 | $0.21 | $-0.25 | 183.2% |
| Dec. 31, 2025 | $-0.43 | $0.11 | -487.0% | |
| Sept. 30, 2025 | $1.06 | $-0.12 | 974.6% | |
| June 30, 2025 | $0.16 | $-0.49 | 132.3% | |
| March 31, 2025 | $0.71 | $0.44 | 59.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.03 | $8.89 | $12.44 | · | $31.56 | $27.25 | $21.05 | $19.74 | $18.47 | $14.69 | $16.75 | $14.67 | |
| Revenue / Share | $13.10 | $19.69 | $20.49 | $22.31 | $33.14 | $28.91 | $21.11 | $15.22 | $11.14 | $9.91 | $11.06 | $9.83 | |
| Cash Flow / Share | $3.01 | $1.11 | $-4.03 | $-0.68 | $5.94 | $9.96 | $3.59 | $0.81 | $4.14 | $1.08 | $0.94 | $2.45 | |
| Cash / Share | $3.94 | $1.83 | $2.14 | · | $11.23 | $11.70 | $3.25 | $2.19 | $3.61 | $6.69 | $7.94 | $7.44 | |
| EPS (TTM) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | · | 53,200,000 | 54,200,000 | 54,400,000 | · | 53,100,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | · | 56,500,000 | 54,200,000 | 57,300,000 | · | 55,600,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $10.10 | · | $11.05 | $9.99 | $10.14 | · | $9.40 | $7.30 | $12.67 | · | $13.46 | $18.46 | $23.86 | · | $29.04 | |
| Revenue / Share | $4.54 | $2.76 | · | $4.09 | $2.60 | $3.88 | · | $5.28 | $4.84 | $5.75 | · | $5.22 | $6.66 | $3.29 | · | $4.81 | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.20 | · | · | · | $-1.20 | · | · | · | $-3.67 | · | · | |
| Cash / Share | $2.72 | $3.09 | · | $4.66 | $4.98 | $2.74 | · | $2.77 | $1.32 | $1.50 | · | $1.70 | $1.71 | $8.54 | · | $4.83 | |
| EPS (TTM) | $-3.46 | $-0.19 | · | $1.43 | $2.58 | $-2.58 | · | $-4.05 | $-11.19 | $-10.97 | · | $-15.27 | $-11.94 | $-7.84 | · | $0.40 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $770M | $677M | · | $789M | $852M | $965M | · | $1.13B | $1.10B | $1.19B | · | $1.10B | $1.07B | $977M | · | $1.49B | |
| Net Income TTM | $-177M | $-9M | · | $76M | $140M | $-132M | · | $-209M | $-587M | $-565M | · | $-778M | $-602M | $-393M | · | $33M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -2.4 | -43.7 | · | 6.2 | 2.5 | -1.9 | · | -2.1 | -0.6 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 52.5 | |
| P/S | 0.6 | 0.6 | · | 0.6 | 0.4 | 0.3 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| EV / Revenue | 1.1 | 1.2 | · | 1.1 | 0.9 | 0.8 | · | 0.9 | 1.4 | 1.2 | · | 1.2 | 1.5 | 2.5 | · | 1.3 | |
| Earnings Yield | -41.3% | -2.3% | · | 16.2% | 40.4% | -53.1% | · | -48.5% | -164.1% | -433.6% | · | -449.1% | -162.5% | -75.7% | · | 1.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | · |
| Gross Margin % | · | · | 30.3% | 34.3% | · |
| Operating Margin % | 13.5% | -10.4% | -69.2% | -15.2% | · |
| Net Income | $53M | $-191M | $-760M | $-212M | · |
| Diluted EPS | $0.93 | $-3.60 | $-14.85 | $-4.22 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | · |
| Current Ratio | 5.0 | 3.7 | 1.0 | · | · |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $157M | $36M | $-258M | $-150M | · |
Institutional owners (13F) 209 filers · $391.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
209
Value held
$391.0M
New positions
31
Exited positions
24
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 31 (-7 vs prior Q) | 24 (+1 vs prior Q) | 71 (+1 vs prior Q) | 63 (+9 vs prior Q) | +916K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43,927,428 | 3,553,999 | 11.23% | Shares |
| BlackRock, Inc. | $39,525,100 | 4,716,599 | 10.11% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $25,782,865 | 3,076,646 | 6.59% | Shares |
| STATE STREET CORP | $24,556,367 | 2,929,238 | 6.28% | Shares |
| AMERICAN CENTURY COMPANIES INC | $23,216,354 | 2,770,448 | 5.94% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $18,426,271 | 2,198,839 | 4.71% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,208,910 | 1,337,243 | 2.87% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10,062,629 | 1,200,791 | 2.57% | Shares |
| OAK HILL ADVISORS LP | $9,329,772 | 1,113,338 | 2.39% | Shares |
| MILLENNIUM MANAGEMENT LLC | $8,984,910 | 1,072,185 | 2.30% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $8,724,846 | 1,041,151 | 2.23% | Shares |
| GOLDMAN SACHS GROUP INC | $8,676,828 | 1,035,421 | 2.22% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8,626,129 | 1,029,371 | 2.21% | Shares |
| D. E. Shaw & Co., Inc. | $7,542,905 | 900,108 | 1.93% | Shares |
| Russell Investments Group, Ltd. | $7,202,462 | 859,482 | 1.84% | Shares |
| FEDERATED HERMES, INC. | $6,964,828 | 831,125 | 1.78% | Shares |
| PRUDENTIAL FINANCIAL INC | $6,753,400 | 805,895 | 1.73% | Shares |
| Prescott Group Capital Management, L.L.C. | $6,475,821 | 772,771 | 1.66% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $5,725,610 | 683,247 | 1.46% | Shares |
| NORTHERN TRUST CORP | $5,207,944 | 621,473 | 1.33% | Shares |
| Allianz Asset Management GmbH | $4,556,885 | 543,781 | 1.17% | Shares |
| PALISADE CAPITAL MANAGEMENT, LP | $4,316,191 | 515,059 | 1.10% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $4,306,516 | 513,904 | 1.10% | Shares |
| TWO SIGMA INVESTMENTS, LP | $4,091,820 | 488,284 | 1.05% | Shares |
| MORGAN STANLEY | $3,936,225 | 469,715 | 1.01% | Shares |
| Prosight Management, LP | $3,854,398 | 459,952 | 0.99% | Shares |
| Trexquant Investment LP | $3,753,050 | 447,858 | 0.96% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3,690,745 | 440,423 | 0.94% | Shares |
| UBS Group AG | $3,067,172 | 366,011 | 0.78% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $2,966,378 | 353,983 | 0.76% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,863,614 | 341,720 | 0.73% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $2,757,523 | 329,060 | 0.71% | Shares |
| Values First Advisors, Inc. | $2,526,468 | 301,488 | 0.65% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,420,144 | 288,800 | 0.62% | Call option |
| GLOBEFLEX CAPITAL L P | $2,022,077 | 241,298 | 0.52% | Shares |
| Bank of New York Mellon Corp | $1,840,760 | 219,661 | 0.47% | Shares |
| FMR LLC | $1,794,733 | 214,169 | 0.46% | Shares |
| Brandywine Global Investment Management, LLC | $1,610,632 | 130,310 | 0.41% | Shares |
| DEUTSCHE BANK AG\ | $1,591,513 | 189,918 | 0.41% | Shares |
| Morse Asset Management, Inc | $1,536,339 | 183,334 | 0.39% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $1,465,939 | 174,933 | 0.37% | Shares |
| FRANKLIN RESOURCES INC | $1,398,144 | 166,843 | 0.36% | Shares |
| Y-Intercept (Hong Kong) Ltd | $1,390,066 | 165,879 | 0.36% | Shares |
| ARISTEIA CAPITAL, L.L.C. | $1,355,490 | 161,753 | 0.35% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,275,596 | 152,219 | 0.33% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $1,273,476 | 151,966 | 0.33% | Shares |
| Squarepoint Ops LLC | $1,240,374 | 148,016 | 0.32% | Shares |
| CREDIT AGRICOLE S A | $1,225,994 | 146,300 | 0.31% | Shares |
| Invesco Ltd. | $1,224,024 | 146,065 | 0.31% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1,028,000 | 122,700 | 0.26% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | Aug. 23, 2010 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 48 insiders · 12 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | CEO | March 4, 2019 S | 142,617 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | June 8, 2026 F | 374,083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | March 13, 2012 A | 26,614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | July 1, 2026 S | 159,098 | 0 | 2 | $-58,960 |
| William Hartzel | SVP, Bioservices | June 8, 2026 F | 185,558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | June 8, 2026 F | 202,201 | 0 | 1 | $-306,080 |
| Simon C Lowry | SVP, R&D, CMO | April 29, 2026 A | 177,914 | 0 | 0 | $0 |
| Jessica Perl | SVP, General Counsel, Corp Sec | April 29, 2026 A | 165,286 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | Nov. 13, 2015 S | 25,182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | March 14, 2013 F | 28,000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | March 15, 2011 A | 18,759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | Nov. 11, 2010 M | 6,980 | 0 | 0 | $0 |
| Kathryn C Zoon | Director | April 30, 2026 A | 79,941 | 0 | 2 | $-144,453 |
| Donald W Degolyer | Director | April 30, 2026 A | 129,721 | 0 | 3 | $-317,617 |
| Sujata Tyagi Dayal | Director | April 30, 2026 A | 100,563 | 0 | 3 | $-201,130 |
| Neal Franklin Fowler | Director | April 30, 2026 A | 160,847 | 0 | 0 | $0 |
| Marvin L White | Director | April 30, 2026 A | 113,839 | 0 | 0 | $0 |
| John D Fowler JR | Director | April 30, 2026 A | 30,350 | 0 | 0 | $0 |
| Fuad El-Hibri | Director | Dec. 3, 2021 J | 206,434 | 0 | 0 | $0 |
| Seamus Mulligan | Director | March 19, 2019 A | 56,141 | 0 | 0 | $0 |
| John Niederhuber | Director | May 18, 2016 D | 30,300 | 0 | 0 | $0 |
| Shahzad Malik | Director | June 14, 2007 A | · | 0 | 0 | $0 |
| Intervac, L.L.C. | 10% owner | Sept. 18, 2012 J | 4,344,250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | 10% owner | May 27, 2010 J | 2,265,043 | 0 | 0 | $0 |
| Microscience Investments LTD | 10% owner | March 8, 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | · | April 30, 2026 A | 149,076 | 0 | 0 | $0 |
| Ronald Richard | · | April 30, 2026 A | 123,761 | 0 | 2 | $-263,101 |
| Keith Katkin | · | April 30, 2026 A | 96,294 | 0 | 1 | $-128,183 |
| Joseph C Papa | · | April 29, 2026 A | 493,153 | 0 | 0 | $0 |
| Louis W Sullivan | · | April 30, 2025 A | 139,098 | 0 | 0 | $0 |
| Jennifer Lynne Fox | · | July 11, 2024 A | 186,382 | 0 | 0 | $0 |
| Adam Havey | · | June 9, 2023 A | 174,398 | 0 | 0 | $0 |
| Robert Kramer | · | June 9, 2023 A | 506,059 | 0 | 0 | $0 |
| Jerome M Hauer | · | May 25, 2023 A | 57,508 | 0 | 0 | $0 |
| Katherine Strei | · | Feb. 28, 2023 F | 62,824 | 0 | 0 | $0 |
| Atul Saran | · | Feb. 28, 2023 F | 86,645 | 0 | 0 | $0 |
| George A Joulwan | · | May 26, 2022 A | 40,244 | 0 | 0 | $0 |
| Karen L. Smith | · | May 7, 2021 F | 11,888 | 0 | 0 | $0 |
| Sean Kirk | · | March 31, 2021 F | 17,776 | 0 | 0 | $0 |
| Sue Bailey | · | March 4, 2021 S | 24,427 | 0 | 0 | $0 |
| Denise Esposito | · | March 10, 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | · | June 4, 2008 S | 1,399,764 | 0 | 0 | $0 |
| Joe M Allbaugh | · | May 21, 2008 A | · | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | · | March 28, 2008 S | 1,269,390 | 0 | 0 | $0 |
| Mauro Gibellini | · | June 4, 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | · | May 17, 2007 P | 1,000 | 0 | 0 | $0 |
| Edward Arcuri | · | May 8, 2007 M | 76,722 | 0 | 0 | $0 |
| Robert Calvin Myers | · | Nov. 20, 2006 C | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 61 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EWO · iShares, Inc. | 23.05% | 335,709 SH | Sept. 11, 2026 | Daily |
| EUFN · iShares Trust | 1.19% | 353,714 SH | Sept. 11, 2026 | Daily |
| MTRA · Invesco Actively Managed Exchange-T… | 1.14% | 11,292 SH | Oct. 1, 2026 | Daily |
| MYLD · Cambria ETF Trust | 0.87% | 41,046 NS | July 31, 2026 | N-PORT |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0.69% | 33,118 SH | Oct. 1, 2026 | Daily |
| EZU · iShares, Inc. | 0.57% | 390,787 SH | Sept. 11, 2026 | Daily |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0.40% | 3,381,000 | Oct. 1, 2026 | Daily |
| DMXF · iShares Trust | 0.40% | 26,552 SH | Sept. 11, 2026 | Daily |
| IEV · iShares Trust | 0.32% | 37,421 SH | Sept. 11, 2026 | Daily |
| IVLU · iShares Trust | 0.31% | 102,055 SH | Sept. 11, 2026 | Daily |
| IXG · iShares Trust | 0.28% | 13,907 SH | Sept. 11, 2026 | Daily |
| IEUR · iShares Trust | 0.28% | 179,129 SH | Sept. 11, 2026 | Daily |
| IMTM · iShares Trust | 0.25% | 77,739 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.24% | 673,051 SH | Aug. 19, 2026 | Daily |
| PABD · iShares Trust | 0.23% | 5,313 SH | Sept. 11, 2026 | Daily |
| EFG · iShares Trust | 0.20% | 236,854 SH | Sept. 11, 2026 | Daily |
| VYMI · VANGUARD WHITEHALL FUNDS | 0.20% | 312,634 SH | Aug. 19, 2026 | Daily |
| EFA · iShares Trust | 0.20% | 1,097,211 SH | Sept. 11, 2026 | Daily |
| EFV · iShares Trust | 0.20% | 436,714 SH | Sept. 11, 2026 | Daily |
| IEFA · iShares Trust | 0.17% | 2,312,794 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.15% | 343,523 SH | Sept. 11, 2026 | Daily |
| ESGD · iShares Trust | 0.14% | 123,676 SH | Sept. 11, 2026 | Daily |
| ACWX · iShares Trust | 0.12% | 101,401 SH | Sept. 11, 2026 | Daily |
| PXF · Invesco Exchange-Traded Fund Trust … | 0.11% | 23,661 SH | Oct. 1, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.11% | 2,737,509 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.11% | 56,354 SH | Aug. 19, 2026 | Daily |
| IXUS · iShares Trust | 0.10% | 431,754 SH | Sept. 11, 2026 | Daily |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.09% | 655,464 SH | Aug. 19, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.08% | 57,978 NS | July 31, 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0.08% | 4,120,164 SH | Aug. 19, 2026 | Daily |
| IWC · iShares Trust | 0.07% | 175,885 SH | Sept. 11, 2026 | Daily |
| TOK · iShares Trust | 0.05% | 841 SH | Sept. 11, 2026 | Daily |
| URTH · iShares, Inc. | 0.05% | 28,175 SH | Sept. 11, 2026 | Daily |
| ACWI · iShares Trust | 0.04% | 100,105 SH | Sept. 11, 2026 | Daily |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0.04% | 2,979 SH | Oct. 1, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 242,129 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 45,382 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.03% | 304,251 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 105,903 SH | Oct. 1, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.02% | 792 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.02% | 366,188 SH | Sept. 11, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.02% | 374,907 NS | July 31, 2026 | N-PORT |
| CRBN · iShares Trust | 0.02% | 1,504 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 24,878 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 1,357,340 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 299,394 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 151,590 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 170,332 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2,757 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 140,649 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 5,377 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2,661 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 18,981 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10,026 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 56,305 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 14,557 SH | Sept. 4, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 592,580 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,554,116 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,439 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 499,316 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 279,031 SH | Sept. 11, 2026 | Daily |
EBS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$11.00
+73.8%
1 14.3%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
1 14.3%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-28Mean target $11.00 +73.8%
← Below all targets
Current price $6.33
Low$10.00
Mean$11.00
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026